TIMEFORBED LTD
Company number 06516039 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: B+
Timeforbed Ltd presents a robust constitution with excellent liquidity and a strong, steady heartbeat of profitability. However, the company is showing symptoms of over-exertion through dividend distributions that exceed current earnings, leading to a slight depletion in overall vitality (net assets). While not in any immediate danger, this pattern of extracting more value than is generated could gradually weaken the business's financial immune system if left unchecked.
1. Key Vital Signs
- Liquidity (Blood Pressure): 2.35:1 (Healthy) With current assets of £265,795 against current liabilities of £112,971, the company has more than £2 of short-term assets for every £1 of short-term debt. This indicates excellent, low-risk blood pressure. The business has plenty of working capital to cover its immediate obligations without breaking a sweat.
- Cash Reserves (Hydration): £161,370 (Strong) Even though cash has decreased from its peak of £195,370 in 2024, holding over £161k in the bank means the company is well-hydrated. It has a substantial safety net to weather any sudden economic shocks or unexpected expenses.
- Profitability (Pulse): £54,920 (Steady) The profit for the year has grown to £54,920, up from £43,610 in the prior year. This shows a strong, consistent pulse. The underlying business is generating healthy margins and is commercially viable.
- Dividend Payout Ratio (Exertion Rate): 127% (Elevated Risk) The company paid out £70,000 in dividends against a profit of £54,920. This means the directors are distributing 127% of the current year's earnings. While sustainable for a short period due to accumulated reserves, consistently paying out more than is earned is the financial equivalent of running a marathon every day—it will eventually lead to exhaustion of the company's retained reserves.
2. Symptoms Analysis
Looking beneath the surface, the financial data reveals a few notable symptoms:
- Shrinking Net Assets: Net assets dropped from £199,518 in 2024 to £184,438 in 2025—a £15,080 decrease. This is a direct symptom of the high dividend payouts. Because the dividends (£70k) exceeded the new profit generated (£54.9k), the retained earnings (the company's financial memory and strength) were consumed to make up the difference.
- Rising Director Liabilities: The company owes its directors a combined £48,243 (up from £62,391 owed by the directors in 2024, which has now flipped to the company owing the directors). This shift indicates the directors injected personal funds or deferred compensation to support the business or fund the dividend extraction. It's a sign of commitment, but also a subtle symptom of cash flow management challenges.
- Stock and Debtor Movements: Stocks slightly decreased (from £39,585 to £38,775), which is generally positive (stock is moving). However, debtors increased from £52,555 to £65,650. This suggests the company is waiting longer to get paid by its customers, which could be restricting cash flow despite healthy sales.
3. Diagnosis
Diagnosis: Financially Stable but Experiencing Equity Drain
Timeforbed Ltd is a healthy, profitable retail business with a strong balance sheet and no immediate threats of insolvency. The "patient" has a robust immune system (cash reserves) and a strong heart (profitability).
However, the business is suffering from a mild case of "Equity Drain"—a condition where owners extract value faster than the business generates it. Over the last two years, the company has paid £110,000 in dividends, while only generating £98,530 in profit. This £11,470 shortfall has been funded by historical reserves. While the patient can afford this treatment for now, continuing this habit will gradually erode the company's net worth and reduce its financial resilience over time.
4. Recommendations
To maintain long-term financial wellness and transition from a "B+" to an "A" rating, the following treatment plan is recommended:
- Regulate the Dividend Diet: Align dividend distributions more closely with annual profitability. A healthy payout ratio for a company of this size and nature is typically between 50% and 80%. This will allow retained earnings to rebuild and compound, strengthening the balance sheet.
- Chase Outstanding Debts: With debtors rising by nearly 25% (£13,095 increase), implement stricter credit control procedures. Getting paid faster will improve cash flow and reduce the need to rely on director loans to fund operations or dividends.
- Monitor Director Loan Accounts: The outstanding loan of £48,243 owed to the directors should be formally documented with clear repayment terms. If the company intends to repay this soon, ensure cash flow projections account for both this repayment and the regular trade creditors.
- Reinvest in Growth: With strong cash reserves, consider strategic reinvestment (e.g., marketing, website improvements, or stock optimization) to increase the "metabolism" (turnover) of the business, ensuring future profits can comfortably sustain the desired level of owner withdrawals.